Highly efficient copper-catalyzed N-arylation of nitrogen-containing heterocycles with aryl and heteroaryl halides

Journal of Organic Chemistry

Volumn 72, Issue 8, 2007, Pages 2737-2743

  Zhu, Liangbo ^a   Cheng, Liang ^a   Zhang, Yuxi ^a   Xie, Rugang ^a   You, Jingsong ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; COPPER; ELECTRONS; ESTERS; HALIDE MINERALS; KETONES; SYNTHESIS (CHEMICAL);

HETEROCYCLES; IMIDAZOLES; N-ARYLATION; PYRROLE;

LIGANDS;

AMINE; BENZIMIDAZOLE DERIVATIVE; BROMINE DERIVATIVE; CESIUM; COPPER; ESTER DERIVATIVE; HETEROCYCLIC COMPOUND; HYDROXYL GROUP; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; KETONE DERIVATIVE; NITRILE; ORGANOHALOGEN DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PYRAZOLE DERIVATIVE; PYRROLE DERIVATIVE; PYRROLIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ARTICLE; ARYLATION; CATALYSIS; CATALYST; CHEMICAL ANALYSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; SYNTHESIS;

CATALYSIS; COPPER; HYDROCARBONS, HALOGENATED; IMIDAZOLES; IODIDES; MOLECULAR STRUCTURE; NITROGEN; PYRAZOLES; PYRROLES; TRIAZOLES;

EID: 34247232757     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo062059f     Document Type: Article

References (77)

1. (a) Craig, P. N. In Comprehensive Medicinal Chemistry; Drayton, C. J., Ed.; Pergamon Press: New York, 1991; Vol. 8.
2. (b) Cozzi, P.; Carganico, G.; Fusar, D.; Grassoni, M.; Menichincheri, M.; Pinciroli, V.; Tonani, R.; Vaghi, F.; Salvati, P. J. Med. Chem. 1993, 36, 2964-2972.
3. (c) Negwer, M. In Organic-Chemical Drugs and their Synonyms: An International Survey, 7th ed.; Akademie Verlag GmbH: Berlin, Germany, 1994.
4. Bambal, R.; Haznlik, R. P. J. Org. Chem. 1994, 59, 729-732. Also, see refs 28a, 29c, 31b, and 37.
5. (a) Jacobs, C.; Frotscher, M.; Dannhardt, G.; Hartmann, R. W. J. Med. Chem. 2000, 43, 1841-1851.
6. (b) Fan, J.; Sun, W.; Okamura, T.; Tang, W.; Ueyama, N. Inorg. Chem. 2003, 42, 3168-3175.
7. (c) Choudary, B. M.; Sridhar, C.; Kantam, M. L.; Venkanna, G. T.; Sreedhar, B. J. Am. Chem. Soc. 2005, 127, 9948-9949. Also, see refs 28a, 28b, and 37.
8. Ley, S. V.; Thomas, A. W. Angew. Chem., Int. Ed. 2003, 42, 5400-5449.
9. Aryllead triacetates: (a) López-Alvarado, P.; Avendano, C.; Menéndez, J. C. Tetrahedron Lett. 1992, 33, 659-662.
10. (b) López-Alvarado, P.; Avendano, C.; Menkéndez, J. C J. Org. Chem. 1995, 60, 5678-5682.
11. (c) Elliott, G. I.; Konopelski, J. P. Org. Lett. 2000, 2, 3055-3057.
12. (d) Fedorov, A. U.; Finet, J.-P. Eur. J. Org. Chem. 2004, 9, 2040-2045.
13. Aryl siloxanes: Lam, P. Y. S.; Deudon, S.; Averill, K. M.; Li, R.; He, M. Y.; DeShong, P.; Clark, C. G. J. Am. Chem. Soc. 2000, 122, 7600-7601.
14. Triphenylbismuth derivatives: Fedorov, A. Y.; Finet, J.-P. Tetrahedron Lett. 1999, 40, 2747-2748.
15. Arylstannanes: Lam, P. Y. S.; Clark, C. G.; Saunern, S.; Adams, J.; Averill, K. M.; Chan, D. M. T.; Combs, A. Synlett 2000, 674-676.
16. Diaryliodonium salts: Wang, F.-Y.; Chen, Z.-C.; Zheng, Q.-G. J. Chem. Res. 2004, 206-207.
17. Arylboronic acids: (a) Lam, P. Y. S.; Clark, C. G.; Saubern, S.; Adams, J.; Winters, M. P.; Chan, D. M. T.; Combs, A. Tetrahedron Lett. 1998, 39, 2941-2944.
18. (b) Combs, A. P.; Saubern, S.; Rafalski, M.; Lam, P. Y. S. Tetrahedron Lett. 1999, 40, 1623-1626.
19. (c) Lam, P. Y. S.; Vincent, G.; Clark, C. G.; Deudon, S.; Jadhav, P. K. Tetrahedron Lett. 2001, 42, 3415-3418.
20. (d) Collman, J. P.; Zhong, M. Org. Lett. 2000, 2, 1233-1236.
21. (e) Collman, J. P.; Zhong, M.; Zhang, C.; Costanzo, S. J. Org. Chem. 2001, 66, 7892-7897.
22. (f) Nishiura, K.; Urawa, Y.; Sodab, S. Adv. Synth. Catal. 2004, 346, 1679-1684.
23. Murata, M.; Suzuki, K.; Watanabe, S.; Masuda, Y. J. Org. Chem. 1997, 62, 8569-8571 and references therein.
24. (a) Anderson, K. W.; Tundel, R. E.; Ikawa, T.; Altman, R. A.; Buchwald, S. L. Angew. Chem., Int. Ed. 2006, 45, 6523 -6527.
25. (b) Muci, A. R.; Buchwald, S. L. Top. Curr. Chem. 2002, 219, 131-209.
26. (c) Yang, B. H.; Buchwald, S. L. J. Organomet. Chem. 1999, 576, 125-146.
27. (d) Hartwig, J. F. Angew. Chem., Int. Ed. 1998, 37, 2046-2067.
28. (e) Hartwig, J. F. Acc. Chem. Res. 1998, 31, 852-860.
29. (f) Wolfe, J. P.; Wagan, S.; Marcoux, J.-F.; Buchwald, S. L. Acc. Chem. Res. 1998, 31, 805-818.
30. (g) Jiang, L.; Buchwald, S. L. Palladium-Catalyzed Aromatic Carbon- Nitrogen Bond Formation. In Metal-Catalyzed Cross-Coupling Reactions, 2nd ed.; de Meijere, A., Diederich, F., Eds.; Wiley-VCH: Weinheim, Germany, 2004; pp 699-760.
31. (a) Antilla, J. C.; Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 11684-11688.
32. (b) trans-Cyclohexanediamine (10%) promoted CuI-catalyzed coupling of imidazoles with aryl iodides in dioxane or DMF: Klapars, A.; Antilla, J. C.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 7727-7729.
33. (c) In a later publication, 1,10-phenanthroline was also suggested to be sufficient for aryl iodides: Antilla, J. C.; Baskin, I. M.; Barder, T. E.; Buchwald, S. L. J. Org. Chem. 2004, 69, 5578-5587.
34. (a) Ma, D.; Cai, Q. Synlett 2004, 128-130.
35. (b) Zhang, H.; Cai, Q.; Ma, D. J. Org. Chem. 2005, 70, 5164-5173.
36. (c) Cul-catalyzed C-N bond forming reactions between aryl/heteroaryl bromides and imidazoles in ionic liquid. The majority of aryl bromides investigated are electron-poor or electron-neutral ones, and aryl halides bearing sterically hindered or functional groups had not been disclosed yet: Lv, X.; Wang, Z.; Bao, W. Tetrahedron 2006, 62, 4756-4761.
37. (a) Alcalde, E.; Dinarès, I.; Rodríguez, S.; de Miguel, C. G. Eur. J. Org. Chem. 2005, 1637-1643.
38. (b) Copper(I)-catalyzed N-arylation of azaheterocycles with aryl bromide. However, only one aryl halide substrate (5-bromo-m-xylene) was tested: Kuil, M.; Bekedam, E. K.; Visser, G. M.; van den Hoogenband, A.; Terpstra, J. W.; Kamer, P. C. J.; van Leeuwena, P. W. N. M.; van Strijdoncka, G. P. F. Tetrahedron Lett. 2005, 46, 2405-2409.
39. The majority of copper-catalyzed N-arylation of azoles investigated was aryl ioides: Cristau, H. J.; Cellier, P. P.; Spindler, J. F.; Taillefer, M. Chem. - Eur. J. 2004, 10, 5607-5622.
40. Jerphagnon, T.; van Klink, G. P. M.; de Vries, J. G.; van Koten, G. Org. Lett. 2005, 7, 5241-5244.
41. (a) Xu, L.; Zhu, D.; Wu, F.; Wang, R.; Wan, B. Tetrahedron 2005, 61, 6553-6568.
42. (b) Rao, H.; Jin, Y.; Fu, H.; Jiang, Y.; Zhao, Y. Chem. - Eur. J. 2006, 12, 3636-3646.
43. (c) Zhang, Z.; Mao, J.; Zhu, D.; Wu, F.; Chen, H.; Wan, B. Tetrahedron 2006, 62, 4435-4443.
44. Li, J. et al. just reported that under higher temperature (145-150°C) 2-aminopyrimidine-4,6-diol is an efficient ligand for copper-catalyzed N-arylations of imidazoles with aryl and heteroaryl halides: Xie, Y.; Pi, S; Wang, J.; Yin, D.; Li, J. J. Org. Chem. 2006, 71, 8324-8327.
45. The protocols were applicable to the N-arylation of benzimidazole and imidazole. However, the couplings of other nitrogen heterocycles had not been disclosed yet, and the process required reaction temperatures as high as 130°C: Liu, L.; Frohn, M.; Xi, N.; Dominguez, C.; Hungate, R.; Reider, P. J. J. Org. Chem. 2005, 70, 10135-10138.
46. The commercially unavailable 4,7-dimethoxy-1,10-phenanthroline was described as an efficient ligand for the copper-catalyzed N-arylation of imidazole, but the couplings of other nitrogen heterocycles had not been disclosed yet: Altman, R. A.; Buchwald, S. L. Org. Lett. 2006, 8, 2779-2782.
47. Lan, J.-B.; Chen, L.; Yu, X.-Q.; You, J.-S.; Xie, R. G. Chem. Commun. 2004, 188-189.
48. McKennon, M. J.; Meyers, A. I.; Drauz, K.; Schwarm, M. J. Org. Chem. 1993, 58, 3568-3571.
49. Itsuno, S.; Ito, K.; Hirao, A.; Nakahama, S. J. Chem. Soc. Perkin Trans. 1 1984, 2887-2893.
50. Doyle, F. P.; Mehta, M. D.; Sach, G. S.; Pearson, J. L. J. Chem. Soc. 1958, 4458-4462.
51. Lizarzaburu, M. E.; Shuttleworth, S. J. Tetrahedron Lett. 2003, 44, 4873-4876.
52. (a) Ferguson-Miller, S.; Babcock, G. T. Chem. Rev. 1996, 96, 2889-2907.
53. (b) Ostermeier, C.; Harrenga, A.; Ermler, U.; Michel, H. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 10547-10553.
54. (c) Yoshikawa, S.; ShinzawaItoh, K.; Nakashima, R.; Yaono, R.; Yamashita, E.; Inoue, N.; Yao, M.; Fei, M. J.; Libeu, C. P.; Mizushima, T.; Yamaguchi, H.;Tomizaki, T.; Tsukihara, T. Science 1998, 280, 1723-1729.
55. Cyclic AMP phosphodiesterase inhibitors: (a) Venuti, M. C.; Stephenson, R. A.; Alvarez, R.; Bruno, J. J.; Strosberg, A. M. J. Med. Chem. 1988, 31, 2136-2145.
56. (b) Martinez, G. R.; Walker, K. A. M.; Hirschfeld, D. R.; Bruno, J. J.; Yang, D. S.; Maloney, P. J. J. Med. Chem. 1992, 35, 620-628.
57. Thromboxane synthase inhibitor: (a) Iizuka, K.; Akahane, K.; Momose, D.; Nakazawa, M. J. Med. Chem. 1981, 24, 1139-1148.
58. (b) Cozzi, P.; Carganico, G.; Fusar, D.; Grassoni, M.; Menichincheri, M.; Pinciroli, V.; Tonani, R.; Vaghi, F.; Salvati, P. J. Med. Chem. 1993, 36, 2964-2972.
59. (c) Qiao, J. X.; Cheng, X.; Modi, D. P.; Rossi, K. A.; Luettgen, J. M.; Knabb, R. M.; Jadhav, P. K.; Wexler, R. R. Bioorg. Med. Chem. Lett. 2005, 15, 29-35.
60. Angiotensin-II agonist: Wan, Y.; Wallinder, C.; Plouffe, B.; Beaudry, H.; Mahalingam, A. K.; Wu, X.; Johansson, B.; Holm, M.; Botoros, M.; Karlen, A.; Pettersson, A.; Nyberg, F.; Fandriks, L.; Gallo-Payet, N.; Hallberg, A.; Alterman, M. J. Med. Chem. 2004, 47, 5995-6008.
61. Cardiotonic agent: (a) Sircar, I.; Weishaar, R. E.; Kobylarz, D.; Moos, W. H.; Bristol, J. A. J. Med. Chem. 1987, 30, 1955-1962.
62. (b) Güngör, T.; Fouquet, A.; Teulon, J.-M.; Provost, D.; Cazes, M.; Cloarec, A. J. Med. Chem. 1992, 35, 4455-4463.
63. PDGFR inhibitors: Zhong, C.; He, J.; Xue, C.; Li, Y. Bioorg. Med. Chem. 2004, 12, 4009-4015.
64. PDE5 inhibitors: Jiang, W.; Guan, J.; Macielag, M. J.; Zhang, S.; Qiu, Y.; Kraft, P.; Bhattacharjee, S.; John, T. M.; Haynes-Johnson, D.; Lundeen, S.; Sui, Z. J. Med. Chem. 2005, 48, 2126-2133.
65. Bradykinin B1 antagonist: Su, D.-S.; Markowitz, M. K.; Murphy, K. L.; Wan, B.-L.; Zrada, M. M.; Harrell, C. M.; O'Malley, S. S.; Hess, J. F.; Ransom, R. W.; Chang, R. S.; Wallace, M. A.; Raab, C. E.; Dean, D. C.; Pettibone, D. J.; Freidinger, R. M.; Bock, M. G. Bioorg. Med. Chem. Lett. 2004, 14, 6045-6048.
66. CB-1 antagonist: Lange, J. H. M.; van Stuivenberg, H. H.; Coolen, H. K. A. C.; Adolfs, T. J. P.; McCreary, A. C.; Keizer, H. G.; Wals, H. C.; Veerman, W.; Borst, A. J. M.; de Looff, W.; Verveer, P. C.; Kruse, C. G. J. Med. Chem. 2005, 48, 1823-1838.
67. COX inhibitor: Almansa, C.; Bartroli, J.; Belloc, J.; Cavalcanti, F. L.; Ferrando, R.; Gomez, L. A.; Ramis, I.; Carceller, E.; Merlos, M.; Garcia-Rafanell, J. J. Med. Chem. 2004, 47, 5579-5582.
68. For a recent account, see: Herrmann, W. A. Angew. Chem., Int. Ed. 2002, 41, 1290-1309.
69. (a) Rao, H.; Fu, H.; Jiang, Y.; Zhao, Y. J. Org. Chem. 2005, 70, 8107-8109.
70. (b) Lu, Z.; Twieg, R. J.; Huang, S. D. Tetrahedron Lett. 2003, 44, 6289-6292.
71. Perry, M. C.; Cui, X.; Powell, M. T.; Hou, D.-R.; Reibenspies, J. H.; Burgess, K. J. Am. Chem. Soc. 2003, 125, 113-123.
72. (a) Cristau, H. J.; Cellier, P. P.; Hamada, S.; Spindler, J. F.; Taillefer, M. Org. Lett. 2004, 6, 913-916.
73. (b) Ma, D.; Cai, Q. Org. Lett. 2003, 5, 3799-3802.
74. (c) Gujadhur, R. K.; Bates, C. G.; Venkataraman, D. Org. Lett. 2001, 3, 4315-4317.
75. (d) Buck, E.; Song, Z. J.; Tschaen, D.; Dormer. P. G.; Volante, R. P.; Reider, P. J. Org. Lett. 2002, 4, 1623-1626.
76. Collman, J. P.; Wang, Z.; Zhong, M.; Zeng, L. J. Chem. Soc., Perkin Trans. 1 2000, 1217-1221.
77. Son, S. U.; Park, I. K.; Park, J.; Hyeon, T. Chem. Commun. 2004, 778-779.